• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化患者的肌肉减少症:流行病学、诊断、治疗和预后。

Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis.

机构信息

Department of Infectious Diseases, the Second Affiliated Hospital of Xi'an Jiaotong University.

National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, the Second Affiliated Hospital of Xi'an Jiaotong University.

出版信息

Curr Opin Gastroenterol. 2023 May 1;39(3):131-139. doi: 10.1097/MOG.0000000000000922. Epub 2023 Mar 1.

DOI:10.1097/MOG.0000000000000922
PMID:37144530
Abstract

PURPOSE OF REVIEW

With the development of many international guidelines, research on sarcopenia has increased rapidly, showing that sarcopenia is predictive of adverse outcomes, including increased mortality and impaired mobility, in patients with cirrhosis. The purpose of this article is to review the current evidence concerning the epidemiology, diagnosis, management and predictive value of sarcopenia on the prognosis of patients with cirrhosis.

RECENT FINDINGS

Sarcopenia is a frequent and lethal complication of cirrhosis. Currently, abdominal computed tomography imaging is the most commonly used method to diagnose sarcopenia. In clinical practice, assessing muscle strength and physical performance, such as by measuring handgrip strength and gait speed, is of increasing interest. In addition to the necessary pharmacological therapy, adequate intake of protein, energy and micronutrients, as well as regular moderate-intensity exercise, can help to minimize sarcopenia. Sarcopenia has been shown to be a strong predictor of prognosis in patients with severe liver disease.

SUMMARY

A global consensus is needed on the definition and operational parameters for the diagnosis of sarcopenia. Further research should focus on developing standardized screening, management and treatment protocols for sarcopenia. Adding sarcopenia to existing models may better exploit the effect of sarcopenia on prognosis in patients with cirrhosis, which should be investigated further.

摘要

目的综述

随着众多国际指南的发展,肌肉减少症的研究迅速增加,研究表明肌肉减少症可预测肝硬化患者的不良结局,包括死亡率增加和活动能力受损。本文旨在综述目前关于肝硬化患者肌肉减少症的流行病学、诊断、治疗以及对预后预测价值的证据。

最新发现

肌肉减少症是肝硬化的常见且致命的并发症。目前,腹部计算机断层扫描成像(CT)是诊断肌肉减少症最常用的方法。在临床实践中,评估肌肉力量和身体机能(如握力和步速)越来越受到关注。除了必要的药物治疗外,充足的蛋白质、能量和微量营养素摄入以及规律的中等强度运动有助于最大限度地减少肌肉减少症。肌肉减少症是严重肝病患者预后的强有力预测指标。

总结

需要就肌肉减少症的定义和操作参数达成全球共识。进一步的研究应集中于制定肌肉减少症的标准化筛查、管理和治疗方案。将肌肉减少症纳入现有的模型中可能会更好地利用其对肝硬化患者预后的影响,这需要进一步研究。

相似文献

1
Sarcopenia in cirrhosis: epidemiology, diagnosis, management and prognosis.肝硬化患者的肌肉减少症:流行病学、诊断、治疗和预后。
Curr Opin Gastroenterol. 2023 May 1;39(3):131-139. doi: 10.1097/MOG.0000000000000922. Epub 2023 Mar 1.
2
Handgrip Strength Adds More Prognostic Value to the Model for End-Stage Liver Disease Score Than Imaging-Based Measures of Muscle Mass in Men With Cirrhosis.肝硬化男性患者中,握力比基于影像学的肌肉量测量指标为终末期肝病模型评分提供更多预后价值。
Liver Transpl. 2019 Oct;25(10):1480-1487. doi: 10.1002/lt.25598. Epub 2019 Aug 18.
3
Sarcopenia and Liver Cirrhosis-Comparison of the European Working Group on Sarcopenia Criteria 2010 and 2019.肌肉减少症与肝硬化——2010 年和 2019 年欧洲肌肉减少症工作组标准的比较。
Nutrients. 2020 Feb 20;12(2):547. doi: 10.3390/nu12020547.
4
Sarcopenia in cirrhosis: A practical overview.肝硬化中的肌肉减少症:实用概述。
Clin Med (Lond). 2020 Sep;20(5):489-492. doi: 10.7861/clinmed.2020-0089.
5
Singapore Clinical Practice Guidelines For Sarcopenia: Screening, Diagnosis, Management and Prevention.新加坡肌少症临床实践指南:筛查、诊断、管理和预防。
J Frailty Aging. 2022;11(4):348-369. doi: 10.14283/jfa.2022.59.
6
Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?在预测老年人与健康相关的结果方面,力量测量比肌肉量测量更具优势:是时候摒弃“肌肉减少症”这个术语了吗?
Osteoporos Int. 2017 Jan;28(1):59-70. doi: 10.1007/s00198-016-3691-7. Epub 2016 Jul 9.
7
Utility of handgrip strength (HGS) and bioelectrical impedance analysis (BIA) in the diagnosis of sarcopenia in cirrhotic patients.握力(HGS)和生物电阻抗分析(BIA)在诊断肝硬化患者肌少症中的应用。
BMC Gastroenterol. 2022 Mar 30;22(1):159. doi: 10.1186/s12876-022-02236-7.
8
The sex-specific prognostic utility of sarcopenia in cirrhosis.肝硬化中肌肉减少症的性别特异性预后价值。
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2608-2615. doi: 10.1002/jcsm.13059. Epub 2022 Aug 9.
9
The Geriatric Nutritional Risk Index predicts sarcopenia in patients with cirrhosis.老年营养风险指数可预测肝硬化患者的肌肉减少症。
Sci Rep. 2023 Mar 8;13(1):3888. doi: 10.1038/s41598-023-31065-1.
10
Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.亚洲肌少症共识报告:亚洲肌少症工作组报告
J Am Med Dir Assoc. 2014 Feb;15(2):95-101. doi: 10.1016/j.jamda.2013.11.025.

引用本文的文献

1
Analysis of the current status of computed tomography diagnosis of sarcopenia.肌肉减少症的计算机断层扫描诊断现状分析
Arch Med Sci. 2024 Jul 25;21(2):374-382. doi: 10.5114/aoms/191297. eCollection 2025.
2
Reduced Mastication Is Associated With Dynapenia Markers in Patients With Cirrhosis: A Cross-Sectional Study.咀嚼减少与肝硬化患者的肌肉减少症标志物相关:一项横断面研究。
Int J Hepatol. 2025 May 5;2025:5842659. doi: 10.1155/ijh/5842659. eCollection 2025.
3
The mediating role of social support in self-management and quality of life in patients with liver cirrhosis.
社会支持在肝硬化患者自我管理与生活质量中的中介作用
Sci Rep. 2025 Feb 8;15(1):4758. doi: 10.1038/s41598-024-81943-5.